QA & Compliance

Pharmaceutical Inspection Readiness: A 7-Step Site Preparation Guide

10 min read By Mohammad Awawdeh

Inspection readiness is not something you achieve the week before an inspection - it is the state of your quality system every day. However, targeted preparation in the period before a scheduled or anticipated inspection significantly improves outcomes. This guide gives you a 7-step framework to prepare your site.

Step 1: Know Your Inspection Profile

Before preparing, understand what to expect. Research the inspecting authority's recent focus areas:

  • Review FDA Warning Letters from the past 12 months in your product category
  • Check EU GMP non-compliance statements for your sector
  • Review your own last inspection report and confirm all CAPAs are closed
  • Identify any product complaints, recalls, or OOS events that may trigger inspector attention

Step 2: Conduct a Gap Assessment

A structured gap assessment against the applicable GMP standard (FDA 21 CFR Parts 210/211, EU GMP, WHO GMP, or PIC/S) identifies your highest-risk areas. Prioritise findings by severity and likelihood of inspector detection. Address critical gaps before the inspection - do not assume they will be missed.

Inspection truism: Inspectors are experienced professionals who have seen hundreds of facilities. They know where gaps hide - in deviation records, CAPA effectiveness checks, data integrity controls, and equipment qualification status. They will go there.

Step 3: Verify Documentation is Complete and Current

Documentation is the foundation of every GMP inspection. Verify that:

  • All SOPs are current, approved, and reflect actual practice
  • Training records are complete and up-to-date for all relevant staff
  • Equipment qualification and calibration records are within schedule
  • Validation files are complete, signed, and accessible
  • All open deviations and CAPAs have documented status and are not overdue
  • Change control records are complete for all recent changes

Step 4: Perform a Data Integrity Self-Assessment

Data integrity is the most cited finding in current FDA and EU GMP inspections. Conduct a data integrity walkthrough covering:

  • Audit trail review in laboratory systems - are entries attributable, contemporaneous, original, and accurate?
  • System access controls - are shared logins in use anywhere?
  • Raw data retention - is original data preserved alongside final results?
  • Back-dating practices - do records reflect actual times of events?

Step 5: Prepare and Brief Your Staff

Staff interviews are a core part of any inspection. Inspectors ask direct questions - including to operators, analysts, and technicians on the floor. Brief your team on:

  • How to respond: answer the specific question asked, truthfully, and stop. Do not volunteer additional information.
  • What to say when they do not know: "I don't know but I can find out" is an acceptable answer
  • Escort procedures: who accompanies inspectors in each area and how requests for documents are handled
  • Record retrieval: who is responsible for locating requested records promptly

Step 6: Conduct a Mock Inspection

A mock inspection is the single most effective preparation tool. Bring in an experienced consultant - ideally someone with direct regulatory inspection experience - to conduct a simulated inspection. The mock inspection should include a facility walkthrough, document requests, and staff interviews. Treat the findings as real observations and address them with CAPAs before the actual inspection.

Step 7: Establish Your Inspection Command Structure

Define roles before the inspection begins:

  • Host - senior quality leader who accompanies inspectors throughout
  • Subject matter experts - available for each process area (lab, manufacturing, validation)
  • Document coordinator - centrally retrieves and tracks all documents requested
  • Scribe - records all inspector questions, observations, and requests in real time
  • Back-room team - prepares responses to 483 observations as they arise during the inspection

PHARPRO Inspection Readiness Services

PHARPRO provides structured inspection readiness programmes including gap assessments, mock inspections, staff interview coaching, documentation remediation, and on-site support during inspections. We have supported pharmaceutical clients across Jordan, the UAE, Saudi Arabia, and Egypt in preparing for FDA, EU GMP, and national authority inspections.

PHARPRO - Expert Pharma Consulting

PHARPRO helps pharmaceutical manufacturers prepare for FDA, EU GMP, and national authority inspections - with gap assessments, mock audits, and structured remediation plans.

Inspection Readiness Consulting → Free Assessment
Related Insights

Keep reading

More in-depth guides from the PHARPRO compliance team.

What Is a GMP Gap Assessment?
What a gap assessment covers, when to conduct one, and how PHARPRO structures the engagement.
FDA Warning Letter Response: A Practical Recovery Plan
How to structure your response, address observations effectively, and prevent recurrence.
CAPA Management in Pharmaceutical QA
Root cause analysis, corrective action planning, and effectiveness checks - aligned to FDA and EU GMP.
Data Integrity in Pharma: ALCOA+ Requirements
ALCOA+ principles, FDA and EU GMP expectations, audit trail controls, and the most common gaps.
GMP Training Records: Requirements and Best Practice
What records regulators require, how to structure your training matrix, and what inspectors check.

Ready to strengthen your compliance programme?

Start with a free assessment - no commitment required.

Book Free Assessment WhatsApp